Skip to main content

Ingalls & Snyder LLC

SEC CIK
0001041885
Latest filing
Aug 14, 2026

AZN holding history

AstraZeneca PLC in every 13F filed by Ingalls & Snyder LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overviewAll 13F holders of AZNFull Q2 2026 holdings

Shares (Q2 2026)
29,529
Value
$5.60M
% of portfolio
0.2%
Quarters held
22
Since Q1 2021
Holdings of AZN by Ingalls & Snyder LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202629,529$5.60M0.2%−81−0.3%ReducedHolders
Q1 202629,610$5.84M0.2%+845+2.9%AddedConverted for a 1-for-2 splitHolders
Q4 202557,531$5.29M0.2%−2,794−4.6%ReducedHolders
Q3 202560,325$4.63M0.2%−271−0.4%ReducedHolders
Q2 202560,596$4.23M0.2%−46−0.1%ReducedHolders
Q1 202560,642$4.46M0.1%−973−1.6%ReducedHolders
Q4 202461,615$4.04M0.2%−981−1.6%ReducedHolders
Q3 202462,596$4.88M0.2%−453−0.7%ReducedHolders
Q2 202463,049$4.92M0.2%−941−1.5%ReducedHolders
Q1 202463,990$4.33M0.2%−144−0.2%ReducedHolders
Q4 202364,134$4.32M0.2%−1,558−2.4%ReducedHolders
Q3 202365,692$4.45M0.2%+2,908+4.6%AddedHolders
Q2 202362,784$4.49M0.2%−426−0.7%ReducedHolders
Q1 202363,210$4.39M0.2%−494−0.8%ReducedHolders
Q4 202263,704$4.32M0.2%−5,046−7.3%ReducedHolders
Q3 202268,750$3.77M0.2%−169−0.2%ReducedHolders
Q2 202268,919$4.55M0.2%−1,413−2.0%ReducedHolders
Q1 202270,332$4.67M0.2%−3,940−5.3%ReducedHolders
Q4 202174,272$4.33M0.2%−404−0.5%ReducedHolders
Q3 202174,676$4.49M0.2%+42,302+130.7%AddedHolders
Q2 202132,374$1.94M0.1%−3,970−10.9%ReducedHolders
Q1 202136,344$1.81M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.